Skip to content

ABBOTT: what changed

BE 0403.044.007NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€369.8m
2024 · -€5.4m+€375.2m
Equity
€2.10bn
2024 · €2.11bn-€3.2m
Cash
€1.1m
2024 · €2.6m-€1.5m
Balance sheet total
€2.34bn
2024 · €2.34bn-€1.0m

Largest movements

2024 to 2025
Assets

No asset line moved by more than 1% of the balance sheet total.

    Equity and liabilities
    • Contributions -€369.5m

      down €369.5m (-12.3%), from €3.01bn to €2.65bn

    • Profit (loss) carried forward +€366.2m

      up €366.2m (+38.4%), from -€953.7m to -€587.5m

    Income statement
    • Financial income +€369.3m

      up €369.3m (+279,731%), from €132,030 to €369.5m

      of which Financial income: +€369.3m

    • Turnover +€7.3m

      up €7.3m (+7.4%), from €98.3m to €105.6m

    • Goods and materials +€4.7m

      up €4.7m (+6.6%), from €71.8m to €76.5m

      of which Purchases: +€4.5m

    • Financial charges -€2.8m

      down €2.8m (-37.1%), from €7.6m to €4.8m

    Change in the result, 2024 to 2025

    effect on the result

    For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

    Result 2024 -€5.4m
    Turnover +€7.3m
    Other operating income -€5,486
    Goods and materials -€4.7m
    Services and other goods +€7,059
    Staff costs -€748,934
    Depreciation +€207,539
    Write-downs +€396,827
    Provisions -€193,700
    Other operating charges -€68,202
    Other operating items -€60,530
    Financial income +€369.3m
    Financial charges +€2.8m
    Taxes +€977,861
    Result 2025 €369.8m
    raises the resultlowers the resultnot broken down further in the accounts

    Derived cash bridge

    cash 2024 to 2025

    The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

    From operations +€371.7m
    Investment -€209,647
    Financing -€373.1m
    Cash 2024 €2.6m
    Net result for the year +€369.8m
    Depreciation +€2.5m
    Smaller working-capital items +€910,145
    Receivables within one year -€3.3m
    Trade debts -€2.4m
    Tax, wage and social debts +€1.3m
    Other debts +€2.9m
    Investment in fixed assets (net) -€209,647
    Contributions, distributions and other -€373.1m
    Cash 2025 €1.1m
    brings cash intakes cash out
    Every line side by side 73 lines
    Line Code 2024 2025 Change %
    Total assets 20/58 €2,339,137,298 €2,338,136,381 -€1.0m 0.0%
    Fixed assets 21/28 €2,297,431,549 €2,295,123,494 -€2.3m -0.1%
    Intangible fixed assets 21 €228,495 €228,495 = 0.0%
    Tangible fixed assets 22/27 €15,985,944 €13,684,959 -€2.3m -14.4%
    Furniture and vehicles 24 €251,943 €282,957 +€31,014 +12.3%
    Other tangible fixed assets 26 €15,734,001 €13,399,302 -€2.3m -14.8%
    Assets under construction and advance payments 27 - €2,700 +€2,700
    Financial fixed assets 28 €2,281,217,110 €2,281,210,040 -€7,070 0.0%
    Affiliated companies 280/1 €2,280,122,535 €2,280,122,535 = 0.0%
    Participating interests 280 €2,280,122,535 €2,280,122,535 = 0.0%
    Other financial fixed assets 284/8 €1,094,575 €1,087,505 -€7,070 -0.6%
    Amounts receivable and cash guarantees 285/8 €1,094,575 €1,087,505 -€7,070 -0.6%
    Current assets 29/58 €41,705,749 €43,012,887 +€1.3m +3.1%
    Stocks and contracts in progress 3 €1,141,040 €650,893 -€490,147 -43.0%
    Stocks 30/36 €1,141,040 €650,893 -€490,147 -43.0%
    Goods purchased for resale 34 €1,141,040 €650,893 -€490,147 -43.0%
    Amounts receivable within one year 40/41 €37,767,718 €41,062,238 +€3.3m +8.7%
    Trade receivables 40 €37,554,154 €40,978,362 +€3.4m +9.1%
    Other amounts receivable 41 €213,564 €83,876 -€129,688 -60.7%
    Cash at bank and in hand 54/58 €2,596,730 €1,076,318 -€1.5m -58.6%
    Deferred charges and accrued income 490/1 €200,261 €223,438 +€23,177 +11.6%
    Total equity and liabilities 10/49 €2,339,137,298 €2,338,136,381 -€1.0m 0.0%
    Equity 10/15 €2,108,051,570 €2,104,805,504 -€3.2m -0.2%
    Contributions 10/11 €3,014,624,057 €2,645,169,512 -€369.5m -12.3%
    Capital 10 €3,014,624,057 €2,645,169,512 -€369.5m -12.3%
    Issued capital 100 €3,014,624,057 €2,645,169,512 -€369.5m -12.3%
    Reserves 13 €47,136,843 €47,136,843 = 0.0%
    Non-distributable reserves 130/1 €47,136,843 €47,136,843 = 0.0%
    Legal reserve 130 €47,135,410 €47,135,410 = 0.0%
    Other 1319 €1,433 €1,433 = 0.0%
    Profit (loss) carried forward 14 -€953,709,330 -€587,500,851 +€366.2m +38.4%
    Provisions and deferred taxes 16 €1,004,289 €1,224,082 +€219,793 +21.9%
    Provisions for liabilities and charges 160/5 €1,004,289 €1,224,082 +€219,793 +21.9%
    Other liabilities and charges 164/5 €1,004,289 €1,224,082 +€219,793 +21.9%
    Amounts payable 17/49 €230,081,439 €232,106,795 +€2.0m +0.9%
    Amounts payable within one year 42/48 €229,081,754 €230,883,728 +€1.8m +0.8%
    Trade debts 44 €15,526,089 €13,102,569 -€2.4m -15.6%
    Suppliers 440/4 €15,526,089 €13,102,569 -€2.4m -15.6%
    Taxes, remuneration and social security 45 €3,872,654 €5,201,413 +€1.3m +34.3%
    Taxes 450/3 €304,589 €1,169,968 +€865,379 +284%
    Remuneration and social security 454/9 €3,568,065 €4,031,445 +€463,380 +13.0%
    Other amounts payable 47/48 €209,683,011 €212,579,746 +€2.9m +1.4%
    Accrued charges and deferred income 492/3 €999,685 €1,223,067 +€223,382 +22.3%
    Operating income 70/76A €100,001,138 €107,282,754 +€7.3m +7.3%
    Turnover 70 €98,335,821 €105,622,923 +€7.3m +7.4%
    Other operating income 74 €1,665,317 €1,659,831 -€5,486 -0.3%
    Operating charges 60/66A €97,780,661 €102,975,641 +€5.2m +5.3%
    Goods for resale, raw materials and consumables 60 €71,803,503 €76,538,542 +€4.7m +6.6%
    Purchases 600/8 €70,913,116 €75,432,481 +€4.5m +6.4%
    Change in stocks: decrease (increase) 609 €890,387 €1,106,061 +€215,674 +24.2%
    Services and other goods 61 €9,876,749 €9,869,690 -€7,059 -0.1%
    Remuneration, social security and pensions 62 €12,970,911 €13,719,845 +€748,934 +5.8%
    Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,725,241 €2,517,702 -€207,539 -7.6%
    Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €226,114 -€170,713 -€396,827
    Provisions for liabilities and charges: additions (uses and reversals) 635/8 -€14,196 €179,504 +€193,700
    Other operating charges 640/8 €189,299 €257,501 +€68,202 +36.0%
    Non-recurring operating charges 66A €3,040 €63,570 +€60,530 +1,991%
    Operating profit (loss) 9901 €2,220,477 €4,307,113 +€2.1m +94.0%
    Financial income 75/76B €132,030 €369,460,315 +€369.3m +279,731%
    Recurring financial income 75 €132,030 €369,454,545 +€369.3m +279,726%
    Income from financial fixed assets 750 - €369,454,545 +€369.5m
    Other financial income 752/9 €132,030 - -€132,030
    Non-recurring financial income 76B - €5,770 +€5,770
    Financial charges 65/66B €7,632,637 €4,802,117 -€2.8m -37.1%
    Recurring financial charges 65 €7,632,637 €4,802,117 -€2.8m -37.1%
    Debt charges 650 €7,601,392 €4,738,968 -€2.9m -37.7%
    Other financial charges 652/9 €31,245 €63,149 +€31,904 +102%
    Profit (loss) for the period before taxes 9903 -€5,280,130 €368,965,311 +€374.2m
    Income taxes 67/77 €137,733 -€840,128 -€977,861
    Taxes 670/3 €137,733 - -€137,733
    Tax adjustments and reversals of tax provisions 77 - €840,128 +€840,128
    Profit (loss) for the period 9904 -€5,417,863 €369,805,439 +€375.2m
    Profit (loss) for the period to be appropriated 9905 -€5,417,863 €369,805,439 +€375.2m

    Value

    latest balance sheet 31-12-2025 · indication, not a valuation or advice
    ABBOTT is not an SME

    Its turnover (€105.6m) and balance sheet total (€2.34bn) are both above the SME limits of €50m turnover or €43m balance sheet total. This indication is made for SMEs. For a company of this size market prices set the value, and those prices are not in this range.

    Indicative value of the equity

    Indication, not a valuation or advice
    €1.48bn to €1.65bn

    Midpoint €1.55bn · 50% capitalised earnings, 50% adjusted equity

    Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

    Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

    Adjusted equity €2.10bn
    Capitalised earnings €857.5m to €1.20bn
    Indication €1.48bn to €1.65bn

    Adjusted equity

    balance sheet 31-12-2025
    Equity (10/15)
    €2,104,805,504
    Intangible fixed assets (21)
    -€228,495
    Revaluation of assets
    €0
    Deferred tax on the revaluation
    €0
    Other adjustment
    €0
    Adjusted equity
    €2.10bn

    Capitalised earnings

    net result for the year (9904)
    2025
    €369,805,439
    excluding non-recurring income and charges
    €369,863,239
    2024
    -€5,417,863
    excluding non-recurring income and charges
    -€5,414,823
    2023
    -€4,282,932
    excluding non-recurring income and charges
    -€4,280,605
    2022
    €217,785,510
    excluding non-recurring income and charges
    €217,809,097
    2021
    €66,187,371
    excluding non-recurring income and charges
    €66,174,221
    Average result, excluding non-recurring income and charges
    €120,055,937
    Divided by the capitalisation rate
    14% / 12% / 10%
    Capitalised earnings
    €857.5m / €1.00bn / €1.20bn

    Limits of the indication

    • Checked holds no market prices or comparable transactions.
    • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
    • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
    • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
    • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

    For a valuation to base a decision on, go to a company auditor or a certified accountant.

    Calculation and sources

    Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.